Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Test for Predicting Childhood Diabetes Reconsidered

By LabMedica International staff writers
Posted on 18 Mar 2011
The glycosalated hemoglobin (HbA1c) blood test is a rapid and convenient way of diagnosing diabetes.

The HbA1c test has become the preferred way to diagnose diabetes among the millions of patients who have the disease, but are asymptomatic. More...
The simple test measures longer-term blood sugar levels without requiring patients to fast overnight.

Scientists at the University of Michigan, (Ann Arbor, MI, USA), studied whether the assay could be used to make a diagnosis of diabetes mellitus in adolescents, using the standardized values for adults. For the study, they evaluated the testing results of 1,156 obese and overweight adolescents, aged 12-18 years. The American Diabetes Association, (Alexandria, VA, USA), recommends screening only obese and overweight children because their weight puts them at higher risk for developing diabetes.

Individuals were defined as having diabetes mellitus if their fasting plasma glucose (FPG) was equal to or greater than 126 mg/dL; a 2-hour plasma glucose (2-hr PG) equal to or greater than 200 mg/dL or were prediabetic where the FPG is between 100 and 126 mg/dL; and the 2-hr PG is between 140 and 200 mg/dL. According to the guidelines, individuals without symptoms would be classified as having diabetes if HbA1c values reach 6.5% and as having prediabetes if HbA1c values were between 6.0% and 6.4% on two separate tests.

Only four of the adolescents studied had undiagnosed diabetes mellitus. When assessing FPG to detect diabetes, an HbA1c of 6.5% had sensitivity rates of 75.0% for adolescents and 53.8% adults, although the specificity was higher. Additionally, when assessing FPG to detect diabetes mellitus, an HbA1c of 5.7% had sensitivity rates of 5.0% and 23.1%, and specificity rates of 98.3% and 91.1% for adolescents and adults, respectively. These analyses suggest that HbA1c is a poorer predictor of diabetes mellitus and prediabetes for adolescents compared with adults and performance was poor regardless of whether FPG or 2-hr PG measurements were used.

Joyce M. Lee, MD, MPH, a pediatric endocrinologist, and lead author of the study, said, "We found that hemoglobin A1c is not as reliable a test for identifying children with diabetes and prediabetes compared with adults and using this test in children may lead to missed cases." The study was published online ahead of print on December 30, 2010, in the Journal of Pediatrics.

Related Links:

University of Michigan

American Diabetes Association

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.